Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 12, 2012Current Medical Research and Opinion

Efficacy and safety of ceftazidime–avibactam versus imipenem–cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study

View Full Paper
Ask AI
Bookmark
Share

Authors

JVJosé Antonio VázquezAugusta UniversityLPLuis Demetrio González PatzánHospital General San Juan de DiosDSDavid StricklinBaylor University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vázquez et al. (2012) studied this question.

synapsesocial.com/papers/6a70ca49e5469ee92be17960https://doi.org/10.1185/03007995.2012.748653
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Piperacillin/Tazobactam in the Treatment of Hospitalized Patients with Urinary Tract Infections: an Open Non-Comparative and Multicentered Trial1996 · 9 citations
  2. 2Status report on carbapenemases: challenges and prospects2011 · 121 citations
  3. 3Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria2011 · 311 citations
  4. 4Intravenous Doripenem at 500 Milligrams versus Levofloxacin at 250 Milligrams, with an Option To Switch to Oral Therapy, for Treatment of Complicated Lower Urinary Tract Infection and Pyelonephritis2009 · 80 citations